Press & News

People are different and so is their cancer, patients should be treated individually.

2cureX presented on Sedermera Day, 11th October in Gothenburg

October 15, 2018


CEO Ole Thastrup and CBO Maarten van der Linden presented 2cureX, including the Breaking News that 2cureX has obtained CE-IVD marking on the company’s IndiTreat product. CE-IVD is a key milestone for the company and a trade passport for commercialization of IndiTreat in the European market.